Arnaud Grandeury

USPTO Granted Patents = 14 (Patent Applications = 9)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Basel, CH (2017 - 2020)
Helfrantzkirch, FR (2014 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12419894 - Ribociclib tablet (2025-09-23),

2. 12390468 - Crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide (2025-08-19),

3. 12252479 - Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide (2025-03-18),

4. 12252478 - Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide (2025-03-18),

5. 12064434 - Ribociclib tablet (2024-08-20),

6. 11407735 - Crystalline forms of N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide (2022-08-09),

7. 10934273 - Crystalline forms of 4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-N-methylpicolinamide (2021-03-02),

8. 10799506 - Ribociclib tablet (2020-10-13),

9. 10251868 - Benzothiazolone compound (2019-04-09),

10. 9913828 - Benzothiazolone compound (2018-03-13),

11. 9623012 - Formulation comprising benzothiazolone compound (2017-04-18),

12. 8987448 - Preparation of anhydrous and hydrated polymorphs 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-YL)-1H-benzimidazol-2-YL]-1H-quinolin-2-one-lactic acid salt (2015-03-24),

13. 8933108 - Benzothiazolone compound (2015-01-13),

14. 8884014 - Method for purifying a fused pyrrolocarbazole derivative (2014-11-11),

Title: Arnaud Grandeury: Innovator in Pharmaceutical Patents

Introduction

Arnaud Grandeury is a notable inventor based in Helfrantzkirch, France. He has made significant contributions to the pharmaceutical industry, holding a total of 14 patents. His work primarily focuses on innovative drug formulations and delivery systems.

Latest Patents

One of Grandeury's latest patents is for a ribociclib tablet. This patent discloses an oral tablet formulation of ribociclib, including its salt(s). One embodiment of this patent describes a tablet with a high drug load and an immediate release profile. Additionally, he has developed a coated tablet of ribociclib, where the coating serves as an aqueous moisture barrier, specifically using Opadry® amb II coating, which is PVA-based. Furthermore, he has provided new crystalline forms of succinate salts of 7-Cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide, along with pharmaceutical compositions and methods of treatment utilizing these forms.

Career Highlights

Grandeury has worked with prominent companies in the pharmaceutical sector, including Novartis AG and Cephalon, Inc. His experience in these organizations has contributed to his expertise in drug development and patenting.

Collaborations

Throughout his career, Grandeury has collaborated with notable professionals in the field, including Robin Alec Fairhurst and Shinji Hatakeyama. These collaborations have likely enhanced his innovative capabilities and broadened his impact on pharmaceutical advancements.

Conclusion

Arnaud Grandeury is a distinguished inventor whose work in pharmaceutical patents has led to significant advancements in drug formulations. His contributions continue to influence the industry and improve treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.